pISSN 1226-6051
eISSN 2508-786X

Table. 1.

Table. 1.

The diseases or settings relevant to hospital pharmacists’ intervention in Korea published from 1992 to 2016

 Patients with disease/settingsNumber of studies Outcome measure
Asthma46,47,49,54,55,56,57)7Emergency visit, Total average number of errors, Assessment of patient’s usage of inhaler, Level of technique of using the device

Intensive Care Unit17,20,29,30,31,37,58)7Acceptance rate of intervention, Total fentanyl use, The number of days of regaining birth weight, Time to prescription of total parenteral nutrition, The incidence of inappropriate prescribing per 1,000

Cancer16,21,25,32,35,41,50)7Acceptance rate of intervention, Self-awareness in hypersensitivity, Incidence rate of peripheral neuropathy cases and symptoms, Rate of prescribing error, The number of medication monitoring, Patient’s satisfaction, Improvement rates of hiccup, constipation, myalgia, anorexia, nausea, neuropathy, and stomatitis

Inpatient2433,36,40,44)5Acceptance rate of intervention, ICER, Time to period of admission, Acceptance rate of intervention, Weight loss during hospital stay

Anticoagulation Service19,28,51,52)4The percentage of INRs maintained within the therapeutic range, Overall satisfaction on ACS

Renal failure27,39,53)3Serum Ca level, The expectation of pharmacotherapy, SF-36

Diabetes43,45,48)3Changes incompliance on medication, HbA1C, Cost, Satisfaction of pharmacotherapy

Organ transplantation15,42)2Acceptance rate of intervention

Antimicrobial Stewardship Program18,34)2The proportion of inappropriate prescriptions

Geriatric medicine22,23)2Average number of medicine per patient

Rheumatoid Arthritis26)1Patients’ medication knowledge

Hypertension38)1Mean percentage of medication compliance

Total44

INR: International Normalized Ratio; ICER: Incremental Cost Effectiveness Ratio; NST: Nutritional Support Team; ACS: Anti-Coagulation Service; SF-36: Short Form Health Survey-36

Korean J Clin Pharm 2019;29:193-201 https://doi.org/10.24304/kjcp.2019.29.3.193
© 2019 Korean J Clin Pharm